Elimusertib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Elimusertib, covering 2025-05-22 to 2026-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]